Alba Guijarro Belmar
Head of Vector Development,
Sania Therapeutics
Avencia Sanchez-Mejias
Chief Executive Officer and Co-Founder,
Integra Therapeutics
Charlotte Smerdon
Senior Director, Clinical Operations,
Purespring Therapeutics
Giandomenico Turchiano
Associate Director,
UCL/AstraZeneca
Nathalie Cartier-Lacave
Senior Vice President Neurobiology,
AskBio
All Speakers
Alberto del Rio Espinola
Director,
GentiBio Inc
Alex Bloom
Senior Vice President & Technical Operations,
Aviadobio
Amin Hajitou
Professor, Reader in Neuroinflammation,
Imperial College London
Breech Conrad Odu
Process Development Scientist,
Merck Life Sciences
Claire Kerridge
Head of Gene Therapy,
MHRA
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
Elina Hessels
Associate Director Analytical Platforms,
uniQure
Ellina Allais
Regulatory Affairs Senior Director,
Cellectis S.A.
Eugenio Macchiarulo
Director of Manufacturing, Science & Technologies,
Barinthus Bio
James Norton
Director of Analytical Development,
MeiraGTx
Jane Kinghorn
Director Translational Research Office,
University College London
Johnson Varghese
Vice President, Head of Analytical Research and Development,
Beam Therapeutics
Julia Berretta
Chief Executive Officer,
Genenspire
Khalid Saeed
Senior Scientist,
AstraZeneca
Koval Smith
Senior Manager DS/DP of Manufacturing, Science & Technologies,
Orchard Therapeutics
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHS Blood and Transplant
Lily Li
Lead Scientist, Analytical Development,
Cell and Gene Therapy Catapult
.jpg?length=600&name=d6849f03-22a9-47a5-aef2-a28b6e43a39a-2-11764368speaker_photo-Profil_Michel_2-(2).jpg)
Michel Degueldre
Lead GT Biophysical Sciences,
UCB
Nina Kotsopoulou
Chief Technology Officer,
Xap Therapeutics
Otmane Boussif
Chief Technology Officer,
Anjarium Biosciences
Pamela Whalley
Associate Director of Chemistry, Manufacturing and Control,
Complement Therapeutics
Patricia Lareo
Value Chain Capability Lead Gene Therapy,
Roche
Paul Carter
Senior Director of Manufacturing, Science & Technologies,
Quell Therapeutics
Peter Pechan
Head of Vector Biology and Discovery,
UCB Biosciences
Rodolphe Clerval
Chief Executive Officer,
Coave Therapeutics
Victor Dillard
Vice President, Strategy & Operations,
Resolution Therapeutics
Vinciane De Cupere
Technical Lead Gene Therapy,
UCB
Yu-Tsan Liu
Senior Scientist,
UCB Pharma
Alix Eastham
Senior Manager,
Ultragenyx Gene Therapy
Amish Patel
VP of Technical Operations,
Calidi Biotherapeutics
Ashley Winslow
President & CSO,
Odylia Therapeutics
Biren Mistry
Associate Director,
Zentalis Pharmaceuticals
Chien-Chung Chen
Director, Analytical Development,
Cabaletta Bio
Dan Odenwelder
Senior Engineer III,
Biogen
Dan Shelly
VP Business Development,
Prescient Therapeutics
Gargi Roy
Associate Director,
AstraZeneca
Hemant Khanna
VP,
Iveric bio
Irina Klimanskaya
Senior Director,
Astellas Institute for Regenerative Medicine
Jack Scarcelli
Director, Head of Cell Science and Technology,
Pfizer Ltd
John Rossi
Vice President,
CARGO Theraputics Inc
Kenneth Green
Senior Director,
Vertex Pharmaceuticals
Kerry Sieger
Senior Director, Global Quality Operations,
Immatics US, Inc.
Kumkum Saxena
Vice President, Head of Research and Development,
Versatope Therapeutics
Mahwish Natalia
Associate Director,
Takeda
Morten Sogaard
Senior Vice President, Gene Therapy Research and Technical Operations,
Astellas
Nathan Moore
Director,
Takeda
Nelly Viseux
Senior Vice President,Process & AnalyticalDevelopment & ClinicalManufacturing,
2Seventybio
Nicholas Marshall
Head of Protein Sciences,
Invenra
Nitin Garg
Senior Director,
PTC Therapeutics
Shyam Subramanian
Chief Technical Officer,
Obsidian Therapeutics
Stefanie Brady
Sr. Director, Supply Chain,
REGENXBIO
Taylor Forte
Associate Director,
Biogen
William Beck
Director, Supply Chain,
CARISMA Therapeutics
Zhu Zhen Pirot
Platform CGT analytical lead,
Bayer
Julia Matilainen
Head of Patient Operations CGT,
Roche
Kyle Zingaro
Head of Gene Therapy Process Sciences,
UCB
Lindsay Davies
Chief Scientific Officer,
NextCell Pharma AB
Muhammad Akram
Senior Medical Director,
Legend Biotech
Rolf Koehler
Associate Director / Group Head,
Novartis
Tim Allsopp
Chief Technology Officer,
Laverock Therapeutics
All Speakers
Aisling McMahon
Professor of Law,
Maynooth University
Aline Miller
Principal Investigator, Professor of Biomolecular Engineering and Associate Dean for Business Engagement and Innovation,
University of Manchester
Anna Nowocin
Head of Flow Cytometry Standardisation,
MHRA
Anton Hutter
Partner, Patent Attorney,
Venner Shipley IP
Charlotte Wilding
Patent Attorney,
Venner Shipley
Darren Nesbeth
Associate Professor,
UCL
Djordje Djordjevic
Co-Founder and CEO,
plurify.bio
Francesco Dazzi
Executive Medical Lead Cell Therapies,
AstraZeneca
Gabriel Kent
Analytical Development Scientist,
Resolution Therapeutics
Ibon Garitaonandia
Chief Scientific Officer,
CellProthera
Jim (James) Carlson
Principle Safety Director ATMP Enablement,
Roche
Luz Alonso-Crisostomo
Senior Scientist,
AstraZeneca
Marc Schneider
Director ProductSupply Cell & Gene,
BioNTech
Matthew Gibson
Professor,
University of Manchester
Millie Fox
Senior Scientist,
AstraZeneca
Molly Stevens
Professor at Oxford University & Research Director for Biomedical Materials,
Imperial College London
Monica Raimo
Sr. R&D Manager,
Glycostem Therapeutics
-1.webp?length=600&name=main-qimg-6c062adcbace942e5c2a2ea3ec7caf5a%20(1)-1.webp)
Nicolas Weber
Quality Team Leader,
Novartis Pharma
Nitin Garg
Senior Director,
PTC Therapeutics
Patrizia Ferretti
Professor of Regenerative Biology,
University College London
Rahul Khetan
Venture Capital Associate,
UCB Ventures
Ruth Faram
Co-Founder & Chief Scientific Officer,
HigherSteaks
Sakis Mantalaris
Professor,
Trinity College Dublin & NIBRT
Sarah Albon
Director of Cambridge Cellular Therapy Laboratory,
NHS
Sarah Snykers
Director of Operations,
Legend Biotech
Sarah Howlett
Associate Director,
AstraZeneca
Stephen Sullivan
Chief Operating Officer & Board Member,
iPSirius
Subhankar Mukhopadhyay
Senior Lecturer/Associate Professor,
King's College London
Theodora Weisz
Head of Patient Advocacy and Public Affairs EMEA,
Novartis
Ulrich Dr. Rümenapp
Senior Biotech Program Lead,
Bayer AG
Vicki Coutinho
Managing Director & Consultant,
Geni Consulting